The use of neoadjuvant systemic therapy in the treatment of breast cancer patients is
increasing beyond the scope of locally advanced disease. Imaging provides important …

Diffusion‐weighted imaging (DWI) is increasingly being incorporated into routine breast MRI
protocols in many institutions worldwide, and there are abundant breast DWI indications …

Background Accurate identification of pCR to neoadjuvant chemotherapy (NAC) is essential
for determining appropriate surgery strategy and guiding resection extent in breast cancer …

Purpose: We evaluated the performance of the newly proposed radiomics of multiparametric
MRI (RMM), developed and validated based on a multicenter dataset adopting a radiomic …

Purpose To determine if the change in tumor apparent diffusion coefficient (ADC) at diffusion-
weighted (DW) MRI is predictive of pathologic complete response (pCR) to neoadjuvant …

The achievement of the pathologic complete response (pCR) has been considered a metric
for the success of neoadjuvant chemotherapy (NAC) and a powerful surrogate indicator of …

Background It has been proposed that magnetic resonance imaging (MRI) be used to guide
breast cancer surgery by differentiating residual tumor from pathologic complete response …

Purpose To assess diagnostic accuracy with diffusion kurtosis imaging (DKI) in patients with
breast lesions and to evaluate the potential association between DKI-derived parameters …

Diffusion-weighted imaging relies on the detection of the random microscopic motion of free
water molecules known as Brownian movement. With the development of new magnetic …

During their development, cancers acquire several functional capabilities, which are defined
as the hallmarks of cancer. For a deeper understanding of the hallmarks of cancer, and …